Oxford BioDynamics Plc (OBD.L)

41.00 -6.00 (-12.77%) At close: 06:26PM BST

Oxford BioDynamics Plc

3140 Rowan Place
John Smith Drive Oxford Business Park South
Oxford OX4 2WB
United Kingdom
44 1865 518 910
https://www.oxfordbiodynamics.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 43

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.	CEO & Exec. Director	540k	N/A	1963
Mr. Paul Leslie Stockdale F.C.A., M.A.	CFO & Exec. Director	205.97k	N/A	1975
Dr. Alexandre Akoulitchev M.A., Ma (Oxon), Ph.D.	Chief Scientific Officer & Exec. Director	229.45k	N/A	1962
Mr. Thomas G. Guiel B.A.	Chief Operating Officer	N/A	N/A	N/A
Dr. Ewan Hunter B.Sc., BSC, Ph.D., Ph.D., (KCL)	Chief Data Officer	N/A	N/A	N/A
T. Demain	Company Sec.	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Corporate governance

Oxford BioDynamics Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.